News
Transdermal contraceptive patches provide a more convenient delivery system for combined hormonal birth control than daily oral contraceptives. Clinical trials demonstrate that greater numbers of ...
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback